Sep 24, 2025, 18:07
Can BHOC Deliver Oxygen More Efficiently Than Traditional RBC Transfusions?
BHOC – Biological Hemoglobin Oxygen Carrier shared a post on LinkedIn:
”Breakthrough in Hemorrhagic Shock Management
A landmark preclinical study (PMID: 14562727) explored small-volume resuscitation with a hemoglobin-based oxygen carrier (HBOC-201) and its effect on brain tissue oxygenation in severe blood loss (MAP ≈ 40 mmHg).
Key Findings
- Small-volume infusion + 100% oxygen rapidly restored brain tissue oxygenation (PbrO₂ from 7.6 → 44.6 mmHg).
- Mean arterial pressure recovered to ~84% of baseline.
- Effect sustained over 2 hours, without the need for conventional transfusions.
Why it matters
- HBOC-201 creates precious time, supports vital organ function, and bridges recovery in life-threatening scenarios where blood or RBC transfusions may be insufficient. Think of it as a “first-aid kit in a bottle” — minimal volume, maximal impact.
- This aligns with previous findings showing that Biological Hemoglobin Oxygen Carriers (BHOCs) can deliver oxygen more efficiently than traditional RBC transfusions, making them promising tools in trauma and emergency care.

Stay updated with Hemostasis Today.
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH
